GESTILAB INC has a total of 23 patent applications. Its first patent ever was published in 1999. It filed its patents most often in Canada, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and foods and drinks are BIOSPECIFICS TECH CORP, BINDER WILLIAM J and MEDY TOX INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 8 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | New Zealand | 3 | |
#5 | Australia | 2 | |
#6 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Paquin Joanne | 19 |
#2 | Mateescu Mircea-Alexandru | 17 |
#3 | Aouffen Mhamed | 11 |
#4 | Langlois Denis | 11 |
#5 | Wang Xintao | 6 |
#6 | De Grandpre Eric | 5 |
#7 | Mateescu Mircea Alexandru | 2 |
#8 | Grandpre Eric De | 1 |
#9 | Degrandpre Eric | 1 |
#10 | De Grandpr Ric | 1 |
Publication | Filing date | Title |
---|---|---|
CA2373050A1 | Cardioprotective composition and uses thereof | |
CA2373058A1 | Ceruloplasmin and an antioxidant composition comprising the same and their uses as neuroprotective agent | |
CA2373039A1 | Neuroprotective composition and uses thereof | |
CA2373054A1 | Cardioprotective composition comprising ceruloplasmin and uses thereof | |
CA2270853A1 | Ceruloplasmin and antioxidant compositions comprising the same and their uses as neuroprotective agent | |
CA2270795A1 | Neuroprotective compositions and uses thereof | |
CA2271193A1 | Cardioprotective compositions and uses thereof | |
CA2271192A1 | Cardioprotective compositions comprising ceruloplasmine and uses thereof |